Biotech | May 27, 2022
CorePath partners with Cizzle Bio to develop blood test to detect lung cancer
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Data from the three studies formed the basis of the company's application for approval by regulatory agencies
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
The Da Vinci Robotic-Assisted Surgery system, and Advanced Robotic Surgery Centre was inaugurated early this year
Roche and its subsidiary TIB Molbiol have developed three different LightMix Modular Virus kits for the detection of the virus
The partnership aims to enhance HotSpot's drug discovery and development efforts by incorporating GOSTAR's high-quality, annotated datasets into HotSpot's machine learning (ML) and artificial intelligence (AI) models
ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E
For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies
Five patient-first principles to provide the highest standard of healthcare
Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)
Subscribe To Our Newsletter & Stay Updated
